12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · 21h ago
Gainers
- Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 19.6% to $0.29 during Wednesday's after-market session. The company's market cap stands at $2.3 million.
- SeaStar Medical Holding (NASDAQ:ICU) stock moved upwards by 19.19% to $0.5. The market value of their outstanding shares is at $4.0 million.
- Aditxt (NASDAQ:ADTX) shares increased by 14.19% to $1.85. The market value of their outstanding shares is at $2.8 million.
- Vor Biopharma (NASDAQ:VOR) stock rose 13.54% to $0.62. The company's market cap stands at $39.7 million.
- Unicycive Therapeutics (NASDAQ:UNCY) shares increased by 8.06% to $6.7. The company's market cap stands at $83.7 million.
- Plus Therapeutics (NASDAQ:PSTV) stock increased by 7.96% to $0.34. The company's market cap stands at $1.1 million.
Losers
- Reviva Pharmaceuticals (NASDAQ:RVPH) stock declined by 32.5% to $0.52 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
- ZyVersa Therapeutics (NASDAQ:ZVSA) stock fell 7.81% to $0.65. The market value of their outstanding shares is at $3.1 million.
- Aethlon Medical (NASDAQ:AEMD) stock decreased by 7.65% to $1.45. The market value of their outstanding shares is at $3.2 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) stock fell 7.5% to $1.11. The company's market cap stands at $11.5 million.
- 60 Degrees (NASDAQ:SXTP) stock fell 7.12% to $2.35. The company's market cap stands at $3.4 million.
- Evaxion (NASDAQ:EVAX) shares decreased by 7.02% to $2.41. The company's market cap stands at $15.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.